NCT05599425 · RECRUITING

Health Behavior Change in Midlife Adults at Risk for Alzheimer's Disease

This trial tests two versions of a healthy-living education program aimed at helping middle-aged adults make lasting lifestyle changes — better diet, more physical activity, stress management, and mental engagement. Researchers want to know which approach works better for sustaining those changes over time. It is a Phase NA (non-drug, behavioral) study, meaning it is testing whether the program works, with no experimental medication involved.

You may qualify if

  • age 45-69 years
  • normal cognition (Minnesota Cognitive Acuity Scale > 52)
  • English language fluency
  • at least two of the following: i) BMI > 24.9; ii) systolic blood pressure > 125 mmHg; iii) LDL cholesterol > 115 mg/dL; iv) HbA1C > 6.0%; v) at least one APOE ε4 allele; vi) first-degree relative with AD.

You're excluded if

  • history of serious mental illness (i.e., schizophrenia, bipolar disorder)
  • history of neurologic or neurodevelopmental disorder
  • current alcohol or drug use disorder based on self-report
  • current enrollment in an AD prevention clinical trial.

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2024-07-25

View full record on ClinicalTrials.gov

All APOE4 clinical trials